Literature DB >> 19445516

Design and implementation of an ribonucleic acid (RNA) directed fragment library.

Khaled Bodoor1, Vamsi Boyapati, Vikram Gopu, Marietta Boisdore, Kiran Allam, Janae Miller, W Dale Treleaven, Thomas Weldeghiorghis, Fareed Aboul-ela.   

Abstract

The design of RNA binding ligands is complicated by issues of specificity, target flexibility, and the tractability of known RNA inhibitors toward chemical derivitization. To address these difficulties, an RNA-directed fragment compound library is presented. We began with an analysis of 120 small molecules with reported RNA-binding activity. Calculated physical and chemical properties for the RNA ligands are comparable to those of ligands for established protein drug targets. To ensure that our library contained RNA-binding functionalities that might not be detected by the above comparisons, 114 fragment compounds were purchased on the basis of similarity to substructures of RNA ligands. Five "hits" were identified for the decoding site from the bacterial ribosome by NMR. These included fragments derived from A-site binding ligands but also compounds not previously identified as A-site binders. Hits generated in this manner can be used to probe the interaction surface of RNA and its conformational plasticity, facilitating structure-based optimization.

Mesh:

Substances:

Year:  2009        PMID: 19445516     DOI: 10.1021/jm9000659

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  Synthetic small-molecule RNA ligands: future prospects as therapeutic agents.

Authors:  A Di Giorgio; M Duca
Journal:  Medchemcomm       Date:  2019-04-30       Impact factor: 3.597

2.  Structure of the HIV-1 frameshift site RNA bound to a small molecule inhibitor of viral replication.

Authors:  Ryan J Marcheschi; Marco Tonelli; Arvind Kumar; Samuel E Butcher
Journal:  ACS Chem Biol       Date:  2011-06-15       Impact factor: 5.100

3.  A small-molecule probe induces a conformation in HIV TAR RNA capable of binding drug-like fragments.

Authors:  Amy Davidson; Darren W Begley; Carmen Lau; Gabriele Varani
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

4.  Discovery of Key Physicochemical, Structural, and Spatial Properties of RNA-Targeted Bioactive Ligands.

Authors:  Brittany S Morgan; Jordan E Forte; Rebecca N Culver; Yuqi Zhang; Amanda E Hargrove
Journal:  Angew Chem Int Ed Engl       Date:  2017-09-18       Impact factor: 15.336

5.  1,3-Diazepanes of natural product-like complexity from cyanamide-induced rearrangement of epoxy-delta-lactams.

Authors:  Sanjay Dutta; Cody J Higginson; Bao T Ho; Kevin D Rynearson; Sergey M Dibrov; Thomas Hermann
Journal:  Org Lett       Date:  2010-01-15       Impact factor: 6.005

6.  Optimized high-throughput screen for hepatitis C virus translation inhibitors.

Authors:  Katherine E Berry; Betty Peng; David Koditek; Douglas Beeman; Nikos Pagratis; Jason K Perry; Jay Parrish; Weidong Zhong; Jennifer A Doudna; I-hung Shih
Journal:  J Biomol Screen       Date:  2011-02

7.  Screening for inhibitors of the hepatitis C virus internal ribosome entry site RNA.

Authors:  Shou Zhou; Kevin D Rynearson; Kejia Ding; Nicholas D Brunn; Thomas Hermann
Journal:  Bioorg Med Chem       Date:  2013-04-02       Impact factor: 3.641

8.  Novel ligands for a purine riboswitch discovered by RNA-ligand docking.

Authors:  Peter Daldrop; Francis E Reyes; David A Robinson; Colin M Hammond; David M Lilley; Robert T Batey; Ruth Brenk
Journal:  Chem Biol       Date:  2011-03-25

9.  Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes.

Authors:  Amparo Garcia-Lopez; Francesca Tessaro; Hendrik R A Jonker; Anna Wacker; Christian Richter; Arnaud Comte; Nikolaos Berntenis; Roland Schmucki; Klas Hatje; Olivier Petermann; Gianpaolo Chiriano; Remo Perozzo; Daniel Sciarra; Piotr Konieczny; Ignacio Faustino; Guy Fournet; Modesto Orozco; Ruben Artero; Friedrich Metzger; Martin Ebeling; Peter Goekjian; Benoît Joseph; Harald Schwalbe; Leonardo Scapozza
Journal:  Nat Commun       Date:  2018-05-23       Impact factor: 14.919

10.  Using a fragment-based approach to target protein-protein interactions.

Authors:  Duncan E Scott; Matthias T Ehebauer; Tara Pukala; May Marsh; Tom L Blundell; Ashok R Venkitaraman; Chris Abell; Marko Hyvönen
Journal:  Chembiochem       Date:  2013-01-23       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.